83 FR 32905 - Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 136 (July 16, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 136 (July 16, 2018)
| Page Range | 32905-32906 | |
| FR Document | 2018-15138 |
[Federal Register Volume 83, Number 136 (Monday, July 16, 2018)] [Notices] [Pages 32905-32906] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-15138] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 14, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 2, 2017, Siegfried USA, LLC, 33 Industrial Park Rd., Pennsville, NJ 08070 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Gamma Hydroxybutyric Acid............ 2010 I Dihydromorphine...................... 9145 I Hydromorphinol....................... 9301 I [[Page 32906]] Methylphenidate...................... 1724 II Amobarbital.......................... 2125 II Pentobarbital........................ 2270 II Secobarbital......................... 2315 II Codeine.............................. 9050 II Oxycodone............................ 9143 II Hydromorphone........................ 9150 II Hydrocodone.......................... 9193 II Methadone............................ 9250 II Methadone intermediate............... 9254 II Morphine............................. 9300 II Oripavine............................ 9330 II Thebaine............................. 9333 II Opium tincture....................... 9630 II Oxymorphone.......................... 9652 II ------------------------------------------------------------------------ The company plans to manufacture the listed controlled substances in bulk for sale to its customers. Dated: July 10, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-15138 Filed 7-13-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 32905
Transboundary Hydrocarbon Reservoirs of citric acid and certain citrate salts Investigation Nos. 731–TA–1374–1376
in the Gulf of Mexico. These eight from Belgium, Colombia, and Thailand (Final).
stipulations will be added as lease terms that have been found by the U.S. By order of the Commission.
where applicable and will be Department of Commerce (‘‘Commerce’’) Issued: July 10, 2018.
enforceable as part of the lease. to be sold in the United States at less Lisa Barton,
Appendix B of the Gulf of Mexico OCS than fair value (‘‘LTFV’’).2 3 4 Secretary to the Commission.
Oil and Gas Lease Sales: 2017–2022;
Background [FR Doc. 2018–15067 Filed 7–13–18; 8:45 am]
Gulf of Mexico Lease Sales 249, 250,
BILLING CODE 7020–02–P
251, 252, 253, 254, 256, 257, 259, and The Commission, pursuant to section
261; Final Multisale Environmental 735(b) of the Act (19 U.S.C. 1673d(b)),
Impact Statement provides a list and instituted these investigations effective
description of standard post-lease DEPARTMENT OF JUSTICE
June 2, 2017, following receipt of a
conditions of approval that may be petition filed with the Commission and Drug Enforcement Administration
required by BOEM or the Bureau of Commerce by Archer Daniels Midland
Safety and Environmental Enforcement Company, Decatur, Illinois; Cargill, [Docket No. DEA–392]
as a result of plan and permit review Incorporated, Minneapolis, Minnesota;
processes for the Gulf of Mexico OCS Bulk Manufacturer of Controlled
and Tate & Lyle Ingredients Americas,
Region. Substances Application: Siegfried
LLC, Hoffman Estates, Illinois. The
After careful consideration, BOEM USA, LLC
Commission scheduled the final phase
has selected the preferred alternative of the investigations following ACTION: Notice of application.
(Alternative A) in the 2018 GOM notification of a preliminary
Supplemental EIS for proposed Lease determination by Commerce that DATES: Registered bulk manufacturers of
Sale 251. BOEM’s selection of the imports of citric acid and certain citrate the affected basic classes, and
preferred alternative meets the purpose salts from Belgium, Colombia, and applicants therefore, may file written
and need for the proposed action, as Thailand were being sold at LTFV comments on or objections to the
identified in the 2018 GOM within the meaning of section 733(b) of issuance of the proposed registration on
Supplemental EIS, and provides for the Act (19 U.S.C. 1673b(b)). Notice of or before September 14, 2018.
orderly resource development with the scheduling of the final phase of the
protection of the human, marine, and ADDRESSES: Written comments should
Commission’s investigation and of a be sent to: Drug Enforcement
coastal environments while also public hearing to be held in connection
ensuring that the public receives an Administration, Attention: DEA Federal
therewith was given by posting copies Register Representative/DRW, 8701
equitable return for these resources and of the notice in the Office of the
that free-market competition is Morrissette Drive, Springfield, Virginia
Secretary, U.S. International Trade 22152.
maintained. Commission, Washington, DC, and by
Authority: This Notice of Availability of a publishing the notice in the Federal SUPPLEMENTARY INFORMATION: The
Record of Decision is published pursuant to Register of February 2, 2018 (83 FR Attorney General has delegated his
the regulations (40 CFR part 1505) 4922). The hearing was held in authority under the Controlled
implementing the provisions of the National Washington, DC, on May 14, 2018, and Substances Act to the Administrator of
Environmental Policy Act of 1969, as all persons who requested the the Drug Enforcement Administration
amended (42 U.S.C. 4321 et seq.). opportunity were permitted to appear in (DEA), 28 CFR 0.100(b). Authority to
Dated: July 11, 2018. person or by counsel. exercise all necessary functions with
Walter D. Cruickshank, respect to the promulgation and
The Commission made these
Acting Director, Bureau of Ocean Energy implementation of 21 CFR part 1301,
determinations pursuant to section
Management. incident to the registration of
735(b) of the Act (19 U.S.C. 1673d(b)).
[FR Doc. 2018–15181 Filed 7–13–18; 8:45 am] manufacturers, distributors, dispensers,
It completed and filed its
importers, and exporters of controlled
BILLING CODE 4310–MR–P determinations in these investigations
substances (other than final orders in
on July 10, 2018. The views of the
connection with suspension, denial, or
Commission are contained in USITC
revocation of registration) has been
INTERNATIONAL TRADE Publication 4799 (July 2018), entitled
redelegated to the Assistant
COMMISSION Citric Acid and Certain Citrate Salts
Administrator of the DEA Diversion
from Belgium, Colombia, and Thailand:
[Investigation No. 731–TA–1374–1376 Control Division (‘‘Assistant
(Final)] Administrator’’) pursuant to section 7 of
2 Citric Acid and Certain Citrate Salts from
Thailand: Affirmative Final Determination of Sales
28 CFR part 0, appendix to subpart R.
Citric Acid and Certain Citrate Salts In accordance with 21 CFR
at Less Than Fair Value and Final Affirmative
From Belgium, Colombia, and Thailand Determination of Critical Circumstances in Part, 82 1301.33(a), this is notice that on
FR 25998, June 5, 2018; Citric Acid and Certain November 2, 2017, Siegfried USA, LLC,
Determination Citrate Salts from Belgium: Affirmative Final
Determination of Sales at Less Than Fair Value, 82
33 Industrial Park Rd., Pennsville, NJ
On the basis of the record 1 developed 08070 applied to be registered as a bulk
FR 26001, June 5, 2018; Citric Acid and Certain
in the subject investigations, the United Citrate Salts from Colombia: Affirmative Final manufacturer for the basic classes of
States International Trade Commission Determination of Sales at Less Than Fair Value and controlled substances:
sradovich on DSK3GMQ082PROD with NOTICES
(‘‘Commission’’) determines, pursuant Final Negative Determination of Critical
to the Tariff Act of 1930 (‘‘the Act’’), Circumstances, 82 FR 26002, June 5, 2018.
Controlled
that an industry in the United States is
3 The Commission also finds that imports subject Drug code Schedule
to Commerce’s affirmative critical circumstances
substance
materially injured by reason of imports determination are not likely to undermine seriously
the remedial effect of the antidumping duty order Gamma Hydroxy- 2010 I
1 Therecord is defined in sec. 207.2(f) of the on Thailand. butyric Acid.
Commission’s Rules of Practice and Procedure (19 4 Commissioner Jason E. Kearns did not Dihydromorphine .... 9145 I
CFR 207.2(f)). participate in these investigations. Hydromorphinol ...... 9301 I
VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1](https://thefederalregister.org/doc/83_FR_33041/page/1.svg)
![32906 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices
Controlled DEPARTMENT OF JUSTICE Drive, Springfield, Virginia 22152; and
Drug code Schedule
substance (2) Drug Enforcement Administration,
Drug Enforcement Administration Attn: DEA Federal Register
Methylphenidate ..... 1724 II Representative/DRW, 8701 Morrissette
Amobarbital ............ 2125 II [Docket No. DEA–392]
Drive, Springfield, Virginia 22152.
Pentobarbital .......... 2270 II
Importer of Controlled Substances SUPPLEMENTARY INFORMATION: The
Secobarbital ............ 2315 II
Codeine .................. 9050 II Application: Cerilliant Corporation Attorney General has delegated his
Oxycodone ............. 9143 II
authority under the Controlled
ACTION: Notice of application. Substances Act to the Administrator of
Hydromorphone ...... 9150 II
Hydrocodone .......... 9193 II the Drug Enforcement Administration
DATES: Registered bulk manufacturers of (DEA), 28 CFR 0.100(b). Authority to
Methadone .............. 9250 II
the affected basic classes, and exercise all necessary functions with
Methadone inter- 9254 II
mediate.
applicants therefore, may file written respect to the promulgation and
Morphine ................. 9300 II comments on or objections to the implementation of 21 CFR part 1301,
Oripavine ................ 9330 II issuance of the proposed registration on incident to the registration of
Thebaine ................. 9333 II or before August 15, 2018. Such persons manufacturers, distributors, dispensers,
Opium tincture ........ 9630 II may also file a written request for a importers, and exporters of controlled
Oxymorphone ......... 9652 II hearing on the application on or before substances (other than final orders in
August 15, 2018. connection with suspension, denial, or
The company plans to manufacture ADDRESSES: Written comments should revocation of registration) has been
the listed controlled substances in bulk be sent to: Drug Enforcement delegated to the Assistant Administrator
Administration, Attention: DEA Federal of the DEA Diversion Control Division
for sale to its customers.
Register Representative/DRW, 8701 (‘‘Assistant Administrator’’) pursuant to
Dated: July 10, 2018. Morrissette Drive, Springfield, Virginia section 7 of 28 CFR part 0, appendix to
John J. Martin, 22152. All requests for hearing must be subpart R.
Assistant Administrator. sent to: Drug Enforcement In accordance with 21 CFR
[FR Doc. 2018–15138 Filed 7–13–18; 8:45 am] Administration, Attn: Administrator, 1301.34(a), this is notice that on June
8701 Morrissette Drive, Springfield, 12, 2018, Cerilliant Corporation, 811
BILLING CODE 4410–09–P
Virginia 22152. All request for hearing Paloma Drive, Suite A, Round Rock,
should also be sent to: (1) Drug Texas 78665 applied to be registered as
Enforcement Administration, Attn: an importer of the following basic
Hearing Clerk/LJ, 8701 Morrissette classes of controlled substances:
Controlled substance Drug code Schedule
3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I
Cathinone ........................................................................................................................................................................ 1235 I
Methcathinone ................................................................................................................................................................. 1237 I
4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I
Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I
Naphyrone ....................................................................................................................................................................... 1258 I
N-Ethylamphetamine ....................................................................................................................................................... 1475 I
N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I
Fenethylline ..................................................................................................................................................................... 1503 I
Methaqualone .................................................................................................................................................................. 2565 I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. 6250 I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 7008 I
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoropentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................. 7011 I
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... 7024 I
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. 7031 I
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .................................................................... 7104 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... 7122 I
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I
sradovich on DSK3GMQ082PROD with NOTICES
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I
Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I
Ibogaine ........................................................................................................................................................................... 7260 I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I
VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1](https://thefederalregister.org/doc/83_FR_33041/page/2.svg)
Document Created: 2018-07-14 00:54:26
Document Modified: 2018-07-14 00:54:26
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 14, 2018. | |
| FR Citation | 83 FR 32905 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR